Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indian Drug Makers Thrive With Focus On Catering To Poor Countries

This article was originally published in PharmAsia News

Executive Summary

Despite its relatively poor health care, India is seeing its pharmaceutical companies growing at a fast rate as they produce innovative drugs needed in poorer companies. Troikaa Pharmaceuticals is ready to launch its injectible Dynapar AQ in smaller, more-affordable doses and in poorer countries in Africa, Latin America, former Soviet republics and the European Union. Sami Labs focuses on its herb-based Ayurveda, which makes available a psoriasis treatment at only 10 percent of the cost of chemical-based drugs for the ailment. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts